TapewireFind a company

organization · Reporting owner

Alta Partners VIII, L.P.

Disclosed activity across 2 companies

Tapewire entity
110408
SEC CIK
0001399763

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Allakos Inc.

Report date August 16, 2023 · Filed August 18, 2023

Jointly reported with Alta Partners Management VIII, LLC

Section 16 reporting ended · disclosed 2023-08-18. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Alta Partners VIII, L.P.0 Reported balance After 2023-08-16 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-08-16 · Other · Disposed 6,448,053 · Balance 0

F1: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Partners VIII, L.P. ("Alta VIII") in connection with the winding down of its operations, without consideration, to its general partner and limited partners.

F2: The shares are directly held by Alta VIII. Alta Partners Management VIII, LLC ("Alta Management VIII") is the general partner of Alta VIII and, as such, may be deemed to share voting and investment control with respect to the shares held by Alta VIII. Alta Management VIII disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of its pecuniary interest therein.

Common StockSEC Table I · non-derivativeDirect1,463,378 Reported balance After 2023-08-16 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2023-08-16 · Other · Acquired 1,463,378 · Balance 1,463,378

F3: Represents receipt of shares in the distribution in kind described in footnote (1).

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2023-08-16 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2023-08-16 · Other · Disposed 1,463,378 · Balance 0

F4: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Management VIII, without consideration, to its members.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Partners VIII, L.P. ("Alta VIII") in connection with the winding down of its operations, without consideration, to its general partner and limited partners.

F2: The shares are directly held by Alta VIII. Alta Partners Management VIII, LLC ("Alta Management VIII") is the general partner of Alta VIII and, as such, may be deemed to share voting and investment control with respect to the shares held by Alta VIII. Alta Management VIII disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of its pecuniary interest therein.

F3: Represents receipt of shares in the distribution in kind described in footnote (1).

F4: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Management VIII, without consideration, to its members.

SUTRO BIOPHARMA, INC.

Report date October 01, 2018 · Filed October 01, 2018

Jointly reported with Alta Partners Management VIII, LLC, CHAMPSI FARAH, JANNEY DANIEL, NOHRA GUY P

Section 16 reporting ended · disclosed 2018-10-01. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect1,944,901 Last balance in matching sequence After 2018-10-01 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rows

Row 1 · 2018-10-01 · Conversion · Acquired 589,661 · Balance 589,661

F1: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Row 2 · 2018-10-01 · Conversion · Acquired 458,331 · Balance 1,047,992

F3: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Row 3 · 2018-10-01 · Conversion · Acquired 382,698 · Balance 1,430,690

F4: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Row 4 · 2018-10-01 · Conversion · Acquired 514,211 · Balance 1,944,901

F5: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Series B Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-10-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2018-10-01 · Conversion · Disposed 10,201,769 · Balance 0

F1: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Series C Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-10-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2018-10-01 · Conversion · Disposed 12,387,324 · Balance 0

F3: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-10-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2018-10-01 · Conversion · Disposed 9,449,318 · Balance 0

F4: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Series E Preferred StockSEC Table II · derivative / convertible securityDirect0 Reported balance After 2018-10-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2018-10-01 · Conversion · Disposed 18,698,578 · Balance 0

F5: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F2: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

F3: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F4: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F5: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 16, 2023 Filed Aug 18, 2023 17:21 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 1,463,378 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046608 · doc4.xml · nonDerivative · entry 3

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F4 · kind: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Management VIII, without consideration, to its members.

Read SEC document
August 16, 2023 Filed Aug 18, 2023 17:21 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 1,463,378 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046608 · doc4.xml · nonDerivative · entry 2

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,463,378

F3 · kind: Represents receipt of shares in the distribution in kind described in footnote (1).

Read SEC document
August 16, 2023 Filed Aug 18, 2023 17:21 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 6,448,053 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046608 · doc4.xml · nonDerivative · entry 1

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Alta Partners VIII, L.P.

Disclosed balance after: 0

F1 · kind: Represents a pro-rata in-kind distribution of common stock of the Issuer by Alta Partners VIII, L.P. ("Alta VIII") in connection with the winding down of its operations, without consideration, to its general partner and limited partners.

F2 · ownership.nature: The shares are directly held by Alta VIII. Alta Partners Management VIII, LLC ("Alta Management VIII") is the general partner of Alta VIII and, as such, may be deemed to share voting and investment control with respect to the shares held by Alta VIII. Alta Management VIII disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of its pecuniary interest therein.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 339,084 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 6

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Alta Management VIII

Disclosed balance after: 0

F6 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Management VIII, without consideration, to its members.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 339,084 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 5

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Alta Management VIII

Disclosed balance after: 339,084

F4 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners VIII, L.P. ("Alta VIII") without consideration, to its general partner and limited partners.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 1,513,770 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 4

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,448,053

F4 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners VIII, L.P. ("Alta VIII") without consideration, to its general partner and limited partners.

F5 · ownership.nature: The shares are directly held by Alta VIII and are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. Alta Management VIII disclaims beneficial ownership of all shares held by Alta VIII, except to the extent of its pecuniary interest therein.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 102,651 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 3

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By APNG I Management

Disclosed balance after: 0

F3 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by APNG I Management, without consideration, to its members.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 102,651 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 2

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By APNG I Management

Disclosed balance after: 102,651

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 16:08 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 486,230 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-001973 · doc4.xml · nonDerivative · entry 1

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,071,147

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners.

F2 · ownership.nature: The shares are directly held by APNG I and are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. APNG I Management disclaims beneficial ownership of all shares held by APNG I, except to the extent of its pecuniary interest therein.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 6,837 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 7

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,837

F9 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein.

F9 · ownership.direct: Represents the acquisition of the shares of Common Stock of the Issuer by Guy P. Nohra in connection with the pro-rata distribution described in footnote (1) herein.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 11,539 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 6

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Alta Bioequities, L.P.

Disclosed balance after: 11,539

F8 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein. Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F8 · ownership.nature: Represents the acquisition of the shares of Common Stock of the Issuer by Alta Bioequities, L.P. in connection with the pro-rata distribution described in footnote (5) herein. Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 11,538 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 5

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Hudson Capital LLC

Disclosed balance after: 11,538

F7 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

F7 · ownership.nature: Represents the acquisition of the shares of Common Stock of the Issuer by Hudson Capital, LLC, a limited liability company of which Peter A. Hudson is the managing member, in connection with the pro-rata distribution described in footnote (5) herein. Mr. Hudson disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 11,538 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 4

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,538

F6 · kind: Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein.

F6 · ownership.direct: Represents the acquisition of the shares of Common Stock of the Issuer by Robert J. More in connection with the pro-rata distribution described in footnote (5) herein.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 34,615 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 3

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By APNG I Management

Disclosed balance after: 0

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by APNG I Management, without consideration, to its members.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 34,615 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 2

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By APNG I Management

Disclosed balance after: 34,615

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 18:24 UTC Allakos Inc. ALLK · Entity 79644 OtherCommon Stock 1,000,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-004922 · doc4.xml · nonDerivative · entry 1

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 10,519,200

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners NextGen Fund I L.P. ("APNG I"), without consideration, to its general partner and limited partners.

F2 · ownership.nature: Consists of 2,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta Partners VIII, L.P. ("Alta VIII").

F3 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their respective pecuniary interests therein.

F4 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their respective pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionSeries E Preferred Stock · Derivative 18,698,578 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · derivative · entry 8

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 514,211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F5 · derivative.exercise_date: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F5 · derivative.expiration_date: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionSeries D Preferred Stock · Derivative 9,449,318 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · derivative · entry 7

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 382,698 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F4 · derivative.exercise_date: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F4 · derivative.expiration_date: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionSeries C Preferred Stock · Derivative 12,387,324 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · derivative · entry 6

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 458,331 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F3 · derivative.exercise_date: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F3 · derivative.expiration_date: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionSeries B Preferred Stock · Derivative 10,201,769 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · derivative · entry 5

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 589,661 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F1 · derivative.exercise_date: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F1 · derivative.expiration_date: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionCommon Stock 514,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · nonDerivative · entry 4

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · price: Each share of the issuer's Series E Preferred Stock automatically converted into 0.0275 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionCommon Stock 382,698 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · nonDerivative · entry 3

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,430,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionCommon Stock 458,331 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · nonDerivative · entry 2

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,047,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each share of the issuer's Series C Preferred Stock automatically converted into 0.0370 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
October 01, 2018 Filed Oct 1, 2018 17:12 UTC SUTRO BIOPHARMA, INC. STRO · Entity 5797 ConversionCommon Stock 589,661 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-052831 · doc4.xml · nonDerivative · entry 1

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

JANNEY DANIEL · CIK 0001198325 · Director · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 589,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the issuer's Series B Preferred Stock automatically converted into 0.0578 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.

F2 · ownership.direct: The shares directly held by Alta Partners VIII, L.P. ("Alta VIII") are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

Read SEC document
July 23, 2018 Filed Jul 23, 2018 17:01 UTC Allakos Inc. ALLK · Entity 79644 ConversionSeries B Preferred Stock · Derivative 1,239,007 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-043627 · doc4.xml · derivative · entry 4

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,239,007 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F2 · derivative.exercise_date: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F2 · derivative.expiration_date: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein.

F8 · ownership.nature: APNG I owns 504,547 shares of Series B Preferred Stock. Alta VIII owns 734,460 shares of Series B Preferred Stock.

Read SEC document
July 23, 2018 Filed Jul 23, 2018 17:01 UTC Allakos Inc. ALLK · Entity 79644 ConversionSeries A Preferred Stock · Derivative 10,030,193 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-043627 · doc4.xml · derivative · entry 3

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 10,030,193 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein.

F7 · ownership.nature: APNG I owns 2,941,718 shares of Series A Preferred Stock. Alta VIII owns 7,088,475 shares of Series A Preferred Stock.

Read SEC document
July 23, 2018 Filed Jul 23, 2018 17:01 UTC Allakos Inc. ALLK · Entity 79644 PurchaseCommon Stock 250,000 $18.00 $4,500,000.00
Disclosure

SEC source: 0001209191-18-043627 · doc4.xml · nonDerivative · entry 2

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 11,519,200

F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein.

F6 · ownership.nature: Consists of 3,557,377 shares held of record by APNG I and 7,961,823 shares held of record by Alta VIII.

Read SEC document
July 23, 2018 Filed Jul 23, 2018 17:01 UTC Allakos Inc. ALLK · Entity 79644 ConversionCommon Stock 11,269,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-043627 · doc4.xml · nonDerivative · entry 1

Alta Partners VIII, L.P. · CIK 0001399763 · 10% owner

Alta Partners Management VIII, LLC · CIK 0001399894 · 10% owner

Alta Partners NextGen Fund I Management, LLC · CIK 0001736001 · 10% owner

Alta Partners NextGen Fund I, L.P. · CIK 0001698110 · 10% owner

CHAMPSI FARAH · CIK 0001198321 · 10% owner

Hudson Peter A · CIK 0001674884 · 10% owner

MORE ROBERT J · CIK 0001207792 · 10% owner

NOHRA GUY P · CIK 0001198330 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 11,269,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F2 · price: The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.

F3 · ownership.nature: Consists of 3,446,265 shares held of record by Alta Partners NextGen Fund I, L.P. ("APNG I") and 7,822,935 shares held of record by Alta Partners VIII, L.P. ("Alta VIII").

F4 · ownership.nature: The shares directly held by Alta VIII are indirectly held by Alta Partners Management VIII, LLC ("Alta Management VIII"), which is the general partner of Alta VIII. The individual managing directors of Alta Management VIII are Farah Champsi, Guy Nohra and Daniel Janney. The managing directors of Alta Management VIII exercise sole voting and investment control with respect to the shares held by Alta VIII. The individual managing directors of Alta Management VIII disclaim beneficial ownership of all shares held by Alta VIII, except to the extent of their pecuniary interests therein.

F5 · ownership.nature: The shares directly held by APNG I are indirectly held by Alta Partners NextGen Fund I Management, LLC ("APNG I Management"), which is the general partner of APNG I. The individual managing directors of APNG I Management are Robert More, Peter Hudson and Daniel Janney. The managing directors of APNG I Management exercise sole voting and investment control with respect to the shares held by APNG I. The individual managing directors of APNG I Management disclaim beneficial ownership of all shares held by APNG I, except to the extent of their pecuniary interests therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.